Genentech, member of Roche's company has found positive results for Phase III of their GiACTA study. FDA granted priority review to ensure that Actemra can be made safe and available for patients with giant cell arteritis.
The U.S. Food and Drug Administration (FDA) agreed to speed up the review of Roche's Tecentriq, the immunotherapy drug intended for metastatic urothelial carcinoma.
Roche breast cancer drug 'helps patients live longer', according to a new study. The study found that the drug extended patients' lives by almost 16 months.
A new drug has the potential to treat allergies and asthma.
After accessing the full data on Roche's flu medicine Tamiflu, researchers raised concerns regarding the effectiveness of the medicine in a recent review and said governments who stockpile it are wasting billions of dollars.
Genentech, which is a part of Roche, has announced that its liquid Tamiflu for children is currently in short supply.
In a clinical trial, Roche Holding AG confirms positive result from an experimental cancer drug which shrank lung tumors.